1-1 of 1
other 36 participants in the multicentric retrospective Spanish Study on use of Rituximab in Refractory ITP
Close
Sort by
Journal Articles

Mabthera (Rituximab) in the Treatment of 92 Patients with Refractory Immune Thrombocytopenic Purpura.

JRafael Cabrera, F. Javier Penalver, Isabel Millan, Victor Jimenez-Yuste, Manuel Almagro, Alberto Alvarez-Larran, Lluis Rodriguez, other 36 participants in the multicentric retrospective Spanish Study on use of Rituximab in Refractory ITP
Journal: Blood
Blood (2004) 104 (11): 2074.
https://doi.org/10.1182/blood.V104.11.2074.2074
Published: 2004